Alimera Sciences (ALIM)
(Delayed Data from NSDQ)
$3.49 USD
+0.18 (5.44%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.49 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value B Growth B Momentum C VGM
Income Statements
Fiscal Year end for Alimera Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 81 | 54 | 59 | 51 | 54 |
Cost Of Goods | 11 | 8 | 7 | 7 | 7 |
Gross Profit | 70 | 46 | 52 | 44 | 47 |
Selling & Adminstrative & Depr. & Amort Expenses | 72 | 58 | 52 | 44 | 53 |
Income After Depreciation & Amortization | -2 | -12 | 0 | -1 | -5 |
Non-Operating Income | -8 | -1 | 2 | 0 | 0 |
Interest Expense | 10 | 6 | 5 | 5 | 5 |
Pretax Income | -20 | -18 | -4 | -5 | -10 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -20 | -18 | -4 | -5 | -10 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -20 | -18 | -4 | -5 | -10 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 8 | -8 | 3 | 3 | -2 |
Depreciation & Amortization (Cash Flow) | 10 | 4 | 4 | 4 | 3 |
Income After Depreciation & Amortization | -2 | -12 | 0 | -1 | -5 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 25.56 | 7.00 | 6.60 | 5.12 | 4.77 |
Diluted EPS Before Non-Recurring Items | -0.48 | -2.59 | -0.93 | -1.04 | -2.19 |
Diluted Net EPS (GAAP) | -0.84 | -2.59 | -0.66 | -1.04 | -2.19 |
Fiscal Year end for Alimera Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 26.31 | 23.36 | 17.54 | 13.55 |
Cost Of Goods | NA | 3.63 | 2.76 | 2.43 | 2.03 |
Gross Profit | NA | 22.68 | 20.61 | 15.11 | 11.52 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 21.96 | 18.76 | 16.33 | 14.82 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.72 | 1.85 | -1.22 | -3.30 |
Non-Operating Income | NA | 0.26 | -1.09 | -7.10 | 0.00 |
Interest Expense | NA | 4.75 | 2.07 | 1.69 | 1.67 |
Pretax Income | NA | -3.77 | -1.30 | -10.00 | -4.97 |
Income Taxes | NA | 0.01 | 0.05 | 0.03 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -3.78 | -1.35 | -10.03 | -4.97 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -3.78 | -1.35 | -10.03 | -4.97 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 54.42 | 32.11 | 8.09 | 7.03 |
Diluted EPS Before Non-Recurring Items | NA | -0.07 | -0.06 | -0.44 | -0.71 |
Diluted Net EPS (GAAP) | NA | 1.25 | -0.06 | -1.32 | -0.71 |